Bulletin
Investor Alert

New York Markets Close in:

Oct. 15, 2021, 8:18 a.m. EDT

DEADLINE MONDAY NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

October 15, 2021 (ACCESSWIRE via COMTEX) -- LOS ANGELES, CA / ACCESSWIRE / October 15, 2021 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc. ("Annovis" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Image: https://www.accesswire.com/users/newswire/images/668320/image.png

Investors who purchased the Company's securities between May 21, 2021 and July 28, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before October 18, 2021.

If you are a shareholder who suffered a loss, click here to participate .

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com , or by email at brian@schallfirm.com .

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Annovis's ANVS401 failed to demonstrate statistically significant results across multiple patient populations related to important metrics like judgment and problem-solving ability. Based on this fact, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Annovis, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

SOURCE: The Schall Law Firm

View source version on accesswire.com:

https://www.accesswire.com/668320/DEADLINE-MONDAY-NOTICE-The-Schall-Law-Firm-Reminds-Investors-of-a-Class-Action-Lawsuit-Against-Annovis-Bio-Inc-and-Encourages-Investors-with-Losses-in-Excess-of-100000-to-Contact-the-Firm

COMTEX_395260357/2457/2021-10-15T08:17:37

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright 2021 ACCESSWIRE

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.